title: Vestibular ataxia following shuttle flights: effects of microgravity on otolith-mediated sensorimotor control of posture.
abstract: Orbital spaceflight exposes astronauts to an environment in which gravity is reduced to negligible magnitudes of 10(-3) to 10(-6) G. Upon insertion into earth orbit, the abrupt loss of the constant linear acceleration provided by gravity removes the otolith stimulus for vestibular sensation of vertical orientation constantly present on Earth. Since the central nervous system (CNS) assesses spatial orientation by simultaneously interpreting sensory inputs from the vestibular, visual, and proprioceptive systems, loss of the otolith-mediated vertical reference input results in an incorrect estimation of spatial orientation, which, in turn, causes a degradation in movement control. Over time, however, the CNS adapts to the loss of gravitational signals. Upon return to Earth, the vertical reference provided by gravitational stimulation of the otolith organ reappears. As a result, a period of CNS readaptation must occur upon return to terrestrial environment. Among the physiological changes observed during the postflight CNS readaptation period is a disruption of postural equilibrium control. Using a dynamic posturography system (modified NeuroCom EquiTest), 16 astronauts were tested at 60, 30, and 10 days preflight and retested at 1 to 5 hours, and 8 days postflight. All astronauts tested demonstrated decreased postural stability immediately upon return to Earth. The most dramatic increases in postural sway occurred during those sensory conditions in which both the visual and proprioceptive feedback information used for postural control were altered by the dynamic posturography system, requiring reliance primarily upon vestibular function for control of upright stance. Less marked but statistically significant increases in sway were observed under those conditions in which visual and foot support surface inputs alone were altered.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: KRUG Life Sciences, Houston, Texas.
authors.forename: W H
authors.initials: WH
authors.lastname: Paloski
authors.forename: F O
authors.initials: FO
authors.lastname: Black
authors.forename: M F
authors.initials: MF
authors.lastname: Reschke
authors.forename: D S
authors.initials: DS
authors.lastname: Calkins
authors.forename: C
authors.initials: C
authors.lastname: Shupert
mesh_terms: D000328:Adult; D000337:Aerospace Medicine; D001259:Ataxia / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D007758:Ear, Inner / Q000503:physiopathology; D005260:Female; D006112:Gravitation; D006801:Humans; D008297:Male; D010037:Otolithic Membrane / Q000503:physiopathology*; D011187:Posture; D011597:Psychomotor Performance; D013026:Space Flight; D013028:Space Perception; D014724:Vestibular Function Tests; D014722:Vestibule, Labyrinth / Q000503:physiopathology*